Kagiso Sebina

Kagiso Sebina

Auto-generated profile, based on publicly available information

Kagiso Sebina

BUMMHI, Botswana

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2021 in AIDS
Verified
Journal Article
Closed access
MMMilton Montebatsi
Milton Montebatsi
MLMarie-Claude C. Lavoie
Marie-Claude C. Lavoie
NBNatalia Blanco
Natalia Blanco
RMReson Marima
Reson Marima
KSKagiso Sebina
Kagiso Sebina
NNNdwapi Ndwapi
Ndwapi Ndwapi
Background: In 2019, the Botswana Ministry of Health and Wellness (MOHW) implemented an HIV national Reboot program, which was needed for refocusing and intensifying efforts for achieving epidemic control. The strategies deployed as part of Reboot were reviewed and evaluated for their effect on same-day and within-seven-days (fast-track initiation) antiretroviral therapy (ART) initiation among adults newly identified with HIV. Methods: We conducted a retrospective cohort analysis of patients aged 18 years or older who were newly diagnosed with HIV from October 2018 to September 2019 across 41 health facilities. We used generalized linear mixed models, adjusting for clustering by facility, to assess the association of the Reboot with same-day or within-seven-days ART initiation (fast-track initiation). Results: From October 2018 to January 2019, 28% (636/2269) of newly diagnosed HIV patients were initiated the same day of diagnosis, and 56% (1260/2269) were initiated within seven days. Following the launch of Reboot (February to September 2019), 59% (2092/3553) were initiated the same day of diagnosis, and 77% (2752/3553) were initiated within seven days. Clients were 2.08 (adjusted risk ratio 95% confidence interval 1.79–2.43) times more likely to be initiated the same day of diagnosis and 1.39 (adjusted risk ratio 95% confidence interval 1.28–1.52) times more likely to be initiated within seven days than before Reboot after adjusting for sex and age. Conclusion: In Botswana, a multifaceted national intervention improved timely ART initiation. Identifying and implementing different client-centered strategies to facilitate ART initiation is critical to preventing AIDS-related complications and prevent ongoing transmission.

17 December 2023 in BMJ Global Health
Verified
Conference Paper
Open access
PDF file
OCOntlametse Thato Choga
Ontlametse Thato Choga
SMSikhulile Moyo
Sikhulile Moyo
MMMbatshi Mudanga
Mbatshi Mudanga
KSKagiso Sebina
Kagiso Sebina
Catherine K KoofhethileCatherine K Koofhethile
Catherine K Koofhethile
SGSimani Gaseitsiwe
Simani Gaseitsiwe
Background We evaluated the treatment outcomes of individuals experiencing low-level viremia (LLV) on dolutegravir (DTG) based first-line antiretroviral therapy (ART) in Botswana by determining the trends of LLV over a period of 6 years. Methods We used a large national observational cohort of individuals (aged≥18yrs) who initiated on DTG-based first-line ART for at least 3 months from June 2016 to December 2022. The prevalence of viral suppression (VL ≤50copies/mL), low-level viremia (VL:51-999copies/mL) and virologic failure (VF) (any VL>1000copies/mL) were estimated among PLWH. The prevalence of LLV was further classified into LLV ranges (low-LLV:VL:51-200copies/mL, medium-LLV:201-400copies/mL and high-LLV:VL:401-999copies/mL). Univariate and multivariable Cox proportional hazards regression determined whether LLV (exposure) is associated with VF (outcome). Results Among 50,742 PLWH who have at least one VL measurement during the follow-up, the overall prevalence of LLV by duration strata was 2.2%, 1.8%, 1.7%, 2.3%, 3.1%, 3.7% and 3.9% at 0.25-<0.5, 0.5-≤1, 2, 3, 4, 5, 6+ years respectively. By LLV ranges, ≥90% had low-LLV in each duration strata. A total of 539 had reported LLV at year 0.25-<0.5 whereby 529(98.1%) had single instance of LLV, 9(1.7%) with 2-consecutive-LLV (confirmed) and 1 (0.2%) had at-least-3-LLV(persistent) measurements. The prevalence of PLWH with confirmed-LLV was 9.1%, 9.0%, 7.3%, 6.4%, 9.1% and 8.4% at 0.5-≤1, 2, 3, 4, 5, 6+ years of the follow-up period, respectively. The prevalence of persistent-LLV increased from 0.2% to 7.0% from year 0.25-<0.5 to 6+. PLWH with LLV had an increased risk of VF (adjusted-Hazards-Ratio [aHR] 2.65; 95%CI 2.16–3.26) at a later visit compared to suppressed VL group. High-LLV and persistent-LLV were the main LLV factors associated with VF. Conclusion The prevalence of LLV ranging from 1.7–3.9% was found in this cohort. Having a high or persistent-LLV is associated with a high risk of subsequent VF. Intensified clinical monitoring strategies are warranted for individuals with LLV.

13 April 2018 in JMIR Preprints
Verified
Preprint
Open access
KKKhutsafalo Kadimo
Khutsafalo Kadimo
MKMasego B. Kebaetse
Masego B. Kebaetse
DKDineo Ketshogileng
Dineo Ketshogileng
LSLovie Edwin Seru
Lovie Edwin Seru
KSKagiso B. Sebina
Kagiso B. Sebina
KBKutlo Balotlegi
Kutlo Balotlegi
BACKGROUND The ‘culture’ or ‘habit’ of using personal mobile devices for work and learning is expected to continue growing with advances in information and communication and network technologies. Even with the benefits of users bringing their personal devices to working and learning spaces, the fluid relationship and user movement between medical schools and healthcare facilities can pose challenges for data security, particularly patient information security. The bring-your-own device (BYOD) policy is perceived as a driver for balancing user needs for convenience and institutional needs for security. OBJECTIVE This review sought to explore the literature to identify BYOD policy components (issues, interventions, and guidelines) that could potentially inform BYOD policy development and implementation in healthcare facilities and medical schools. METHODS A literature search on PubMed, Web of Science, and Ebscohost (Academic Search Premier, ERIC, CINAHL, and MEDLINE) was conducted using the following search terms and their synonyms: healthcare facilities, mobile devices, BYOD, privacy and confidentiality, and health records. We developed a review matrix to capture the main aspects of each article and coded the matrix for emerging themes. The database and hand search yielded 1 594 articles, 14 of which were deemed as meeting the inclusion criteria. RESULTS Themes emerging from the study include: device management, data security, medical applications, information technology, education and/or curriculum, policy, and guidelines. The guidelines theme seems to provide a direction for BYOD policy development and implementation. CONCLUSIONS A more feasible approach towards achieving a safe mobile device use environment is through the development of comprehensive BYOD policies that would balance users’ need for convenience with organizational security and patient privacy. The paucity in peer-reviewed literature calls for robust research that uses socio-technical approaches to development and evaluation of BYOD policies in healthcare facilities and medical schools. CLINICALTRIAL none